90 related articles for article (PubMed ID: 11777173)
1. Refractive change after dorzolamide use in patients with primary open-angle glaucoma and ocular hypertension.
Tsai JC; Chang HW
J Ocul Pharmacol Ther; 2001 Dec; 17(6):499-504. PubMed ID: 11777173
[TBL] [Abstract][Full Text] [Related]
2. Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects.
Stewart WC; Day DG; Stewart JA; Holmes KT; Jenkins JN
Eye (Lond); 2004 Sep; 18(9):905-10. PubMed ID: 15002017
[TBL] [Abstract][Full Text] [Related]
3. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
Adamsons IA; Polis A; Ostrov CS; Boyle JE
J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
5. Results of the European Glaucoma Prevention Study.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
[TBL] [Abstract][Full Text] [Related]
7. Fixed topical combinations in glaucomatous patients and ocular discomfort.
Nebbioso M; Evangelista M; Librando A; Di Blasio D; Pescosolido N
Expert Opin Pharmacother; 2012 Sep; 13(13):1829-35. PubMed ID: 22770575
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
Strohmaier K; Snyder E; DuBiner H; Adamsons I
Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
[TBL] [Abstract][Full Text] [Related]
9. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
Schmidt KG; von Rückmann A; Becker R; Pillunat LE
Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
[TBL] [Abstract][Full Text] [Related]
11. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
12. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
Egorov AE
Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
[TBL] [Abstract][Full Text] [Related]
13. An unusual side effect of Dorzolamide.
Zambarakji HJ; Spencer AF; Vernon SA
Eye (Lond); 1997; 11 ( Pt 3)():418-9. PubMed ID: 9373489
[No Abstract] [Full Text] [Related]
14. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
Ozturk F; Ermis SS; Inan UU
Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.
Baiza-Durán LM; Alvarez-Delgado J; Contreras-Rubio AY; Medrano-Palafox J; De Luca-Brown A; Casab-Rueda H; Cortés-Gastélum MA; Garcidueñas-Mejía MJ; Gómez-Bastar P; Gil-Carrasco F; Hartleben-Matkin C; Jiménez-Román J; Moreno-Marín ML; Paczka-Zapata JA; Velasco-Gallegos G; Vergara-Sinta M
Ann Ophthalmol (Skokie); 2009; 41(3-4):174-8. PubMed ID: 20214051
[TBL] [Abstract][Full Text] [Related]
17. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
20. [Ocular hemodynamics and visual field in glaucoma treated with dorzolamide].
Bernd AS; Pillunat LE; Böhm AG; Schmidt KG; Richard G
Ophthalmologe; 2001 May; 98(5):451-5. PubMed ID: 11402826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
